BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20446291)

  • 1. A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach.
    Xie X; Feng S; Vuong H; Liu Y; Goodison S; Lubman DM
    Electrophoresis; 2010 Jun; 31(11):1842-52. PubMed ID: 20446291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion.
    Wang YT; Tsai CF; Hong TC; Tsou CC; Lin PY; Pan SH; Hong TM; Yang PC; Sung TY; Hsu WL; Chen YJ
    J Proteome Res; 2010 Nov; 9(11):5582-97. PubMed ID: 20815410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative phosphoproteome analysis of Streptomyces coelicolor by immobilized zirconium (IV) affinity chromatography and mass spectrometry reveals novel regulated protein phosphorylation sites and sequence motifs.
    Alonso-Fernández S; Arribas-Díez I; Fernández-García G; González-Quiñónez N; Jensen ON; Manteca A
    J Proteomics; 2022 Oct; 269():104719. PubMed ID: 36089190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroporous reversed-phase separation of proteins combined with reversed-phase separation of phosphopeptides and tandem mass spectrometry for profiling the phosphoproteome of MDA-MB-231 cells.
    Ye X; Li L
    Electrophoresis; 2014 Dec; 35(24):3479-86. PubMed ID: 24888630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry.
    Leth-Larsen R; Lund R; Hansen HV; Laenkholm AV; Tarin D; Jensen ON; Ditzel HJ
    Mol Cell Proteomics; 2009 Jun; 8(6):1436-49. PubMed ID: 19321434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a TiO₂ enrichment method for label-free quantitative phosphoproteomics.
    Montoya A; Beltran L; Casado P; Rodríguez-Prados JC; Cutillas PR
    Methods; 2011 Aug; 54(4):370-8. PubMed ID: 21316455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive phosphoproteome analysis of INS-1 pancreatic β-cells using various digestion strategies coupled with liquid chromatography-tandem mass spectrometry.
    Han D; Moon S; Kim Y; Ho WK; Kim K; Kang Y; Jun H; Kim Y
    J Proteome Res; 2012 Apr; 11(4):2206-23. PubMed ID: 22276854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative network analysis of signaling in human CD34(+) hematopoietic progenitor cells by global phosphoproteomic profiling using TiO2 enrichment combined with 2D LC-MS/MS and pathway mapping.
    Guo H; Isserlin R; Chen X; Wang W; Phanse S; Zandstra PW; Paddison PJ; Emili A
    Proteomics; 2013 Apr; 13(8):1325-33. PubMed ID: 23401153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantification of protein phosphorylation sites using liquid chromatography-tandem mass spectrometry-based targeted proteomics: a linear algebra approach for isobaric phosphopeptides.
    Xu F; Yang T; Sheng Y; Zhong T; Yang M; Chen Y
    J Proteome Res; 2014 Dec; 13(12):5452-60. PubMed ID: 25403019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Metabolic ¹⁵N Labeling with Improved Tandem MOAC for Enhanced Probing of the Phosphoproteome.
    Thomas M; Huck N; Hoehenwarter W; Conrath U; Beckers GJ
    Methods Mol Biol; 2015; 1306():81-96. PubMed ID: 25930695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.
    Yu LR; Zhu Z; Chan KC; Issaq HJ; Dimitrov DS; Veenstra TD
    J Proteome Res; 2007 Nov; 6(11):4150-62. PubMed ID: 17924679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tyrosine-phosphorylated proteins associated with lung cancer metastasis using label-free quantitative analyses.
    Wu HY; Tseng VS; Chen LC; Chang HY; Chuang IC; Tsay YG; Liao PC
    J Proteome Res; 2010 Aug; 9(8):4102-12. PubMed ID: 20572634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.
    Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ
    Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry.
    Parker BL; Yang G; Humphrey SJ; Chaudhuri R; Ma X; Peterman S; James DE
    Sci Signal; 2015 Jun; 8(380):rs6. PubMed ID: 26060331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Deciphering cellular processes responding to lethality of 17
    Li Y; Liu X; Wang Y; Liu Z; Ye M; Wang H
    Se Pu; 2024 Apr; 42(4):333-344. PubMed ID: 38566422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoproteomic analysis of human mesenchymal stromal cells during osteogenic differentiation.
    Lo T; Tsai CF; Shih YR; Wang YT; Lu SC; Sung TY; Hsu WL; Chen YJ; Lee OK
    J Proteome Res; 2012 Feb; 11(2):586-98. PubMed ID: 22088210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Leishmania-specific protein phosphorylation sites by LC-ESI-MS/MS and comparative genomics analyses.
    Hem S; Gherardini PF; Osorio y Fortéa J; Hourdel V; Morales MA; Watanabe R; Pescher P; Kuzyk MA; Smith D; Borchers CH; Zilberstein D; Helmer-Citterich M; Namane A; Späth GF
    Proteomics; 2010 Nov; 10(21):3868-83. PubMed ID: 20960452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Phosphoproteomic Analysis of Recombinant Chinese Hamster Ovary Cells Following Temperature Shift.
    Henry M; Power M; Kaushik P; Coleman O; Clynes M; Meleady P
    J Proteome Res; 2017 Jul; 16(7):2339-2358. PubMed ID: 28509555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
    Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
    J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.